Skip to main content
Clinical Trials/JPRN-UMIN000014255
JPRN-UMIN000014255
Recruiting
Phase 3

Examination of aortic diameter changes in patients after thoracic aortic aneurysm surgery with olmesartan or olmesartan + eplerenone - EXPORT trial

Department of Cardiovascular Surgery,Tohoku University School of Medicine0 sites200 target enrollmentJune 13, 2014

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Cardiovascular Surgery,Tohoku University School of Medicine
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 13, 2014
End Date
December 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Cardiovascular Surgery,Tohoku University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • "Patients with thoracic aneurysm induced from congenital connective tissue disorder such as Marfan's syndrome" "Patients with thoracic aneurysm induced from autoimmune disorder such as aortitis syndrome" "Patients with chronic renal failure, which is more than 2\.0mg/dL of serum creatinine concentration, or more than 2g of protein in urine daily" "Patients restricted to take olmesartan or eplerenone" "Patients during pregnancy or expecting to get pregnant" "Patients younger than 20" "Patinets refusing to anticipate this trial" "Patients which we judged unsuitable for this trial"

Outcomes

Primary Outcomes

Not specified

Similar Trials